4-Chlorobutyl Acetate

We are 4-Chlorobutyl Acetate CAS:6962-92-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chlorobutyl Acetate
CAS.NO:6962-92-1
Synonyms:4-Chlorobutyl Acetate
1-Chloro-4-acetoxybutane
4-chloro-1-butanoacetate
4-Chloro-n-butyl acetate
Molecular Formula:C6H11ClO2
Molecular Weight:150.60300
 
Physical and Chemical Properties:
Density:1.072
Boiling point:92ºC
Flash point:148°F
Index of Refraction:1.434
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

4-Chlorobutyl Acetate


Related News: “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”3-(4-Methylbenzylidene)camphor CAS:38102-62-4 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Docosahexaenoic Acid Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.ácido dec-9-enoico CAS:14436-32-9 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.

Related Products
Product Name
2-Bromo-3-methylthiophene View Details
1-(3-methylpyrazin-2-yl)ethanone View Details
3-Chlorobenzyl cyanide View Details
N-Isobutyl-3-nitroquinolin-4-amine manufacturer 4-(2,4-Difluorobenzoyl)-piperidine hydrochloride manufacturer N-Methyl-N-Cbz-D-alanine manufacturer 3-quinuclidinol manufacturer 3-Hydroxy-2-naphthoyl-ortho-phenetidide manufacturer